COMMUNIQUÉS West-GlobeNewswire

Myriad to Announce Fiscal Third-Quarter 2019 Financial Results on May 7, 2019
23/04/2019
SALT LAKE CITY, April 23, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in personalized medicine, today announced that it will hold its fiscal third-quarter 2019 sales and earnings conference [...]
Diversicare to Announce First Quarter 2019 Financial Results on Thursday, May 2, 2019
23/04/2019
BRENTWOOD, Tenn., April 23, 2019 (GLOBE NEWSWIRE) -- Diversicare Healthcare Services, Inc. (NASDAQ:DVCR) today announced that it is scheduled to report financial results for its first quarter ended March 31, 2019, on [...]
NeoChord Raises Additional Financing to Drive Catheter-based Program Development, Bringing Total Series D Funding to over $32 Million
23/04/2019
ST. LOUIS PARK, Minn., April 23, 2019 (GLOBE NEWSWIRE) -- NeoChord, Inc. , a privately-held medical technology company leading the advancement of beating heart mitral valve repair in patients suffering from mitral valve [...]
Galapagos and MorphoSys announce initiation of GECKO Phase 2 study with MOR106 in atopic dermatitis patients
23/04/2019
Mechelen, Belgium and Planegg/Munich, Germany; 23 April 2019; 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG), MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; NASDAQ: MOR) and Novartis Pharma AG (SIX: NOVN [...]
Merit Medical Reports Earnings for Quarter Ended March 31, 2019
23/04/2019
Q1 2019 worldwide revenue of $238.3 million, up 17.4% as reported over Q1 2018 Q1 2019 core revenue on a comparable, constant currency basis* up 10.0% over Q1 2018 Q1 2019 GAAP EPS was $0.11, compared to $0.10 in Q1 [...]
Akari Reports Fourth Quarter and Full Year 2018 Financial Results and Business Highlights
23/04/2019
Treatment with Nomacopan (Coversin) in three patients with mild-to-moderate bullous pemphigoid (BP) resulted in no drug-related adverse events and rapid reduction in BP Disease Area Index (BPDAI) score and blistering in [...]
VitalHub Continues to Report Positive Adjusted EBITDA Results and Increased Revenues
23/04/2019
TORONTO, April 23, 2019 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSXV: VHI) announced today it has filed its Interim Condensed Consolidated Financial Statements and Management's Discussion and [...]
Tonix Pharmaceuticals Announces Update on the Collaborative Research and Development Agreement (CRADA) with the U.S. Army Medical Materiel Development Activity (USAMMDA)
23/04/2019
The Termination Does Not Affect Tonix’s Finances or the Ongoing RECOVERY Trial of Tonmya® for the Treatment of PTSD NEW YORK, April 23, 2019 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix [...]
GW Pharmaceuticals plc to Report Financial Results and Operational Progress for the Period Ending March 31, 2019 and Host Conference Call on May 6, 2019
23/04/2019
LONDON, April 23, 2019 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH, “GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its [...]
Alberta healthcare initiatives recognized for making an impact on patients’ experiences
23/04/2019
CALGARY, Alberta, April 23, 2019 (GLOBE NEWSWIRE) -- The Health Quality Council of Alberta (HQCA) has recognized four initiatives in the province that are making a positive impact on Albertans’ experiences receiving [...]
New Peer Reviewed Data Supports Use of Conformis Customized Knee Implants to Match Anatomic Variability in Patients
23/04/2019
BILLERICA, Mass., April 23, 2019 (GLOBE NEWSWIRE) -- Conformis Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint [...]
UPDATE -- AIT Therapeutics to Demonstrate NO Generator and Delivery System at Pediatric Academic Societies Meeting in Baltimore, MD on April 27-30
23/04/2019
GARDEN CITY, N.Y. and REHOVOT, Israel, April 23, 2019 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (OTCQB: AITB), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide ( [...]
Ossur Hf : Transactions in relation to share buyback program
23/04/2019
Announcement no. 26/2019 23 April 2019 Transactions in relation to share buyback program On 9 October 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2018. The purpose of the share [...]
Inventiva to present new results of its YAP-TEAD oncology program at the AACR Special Conference on The Hippo Pathway
23/04/2019
New study evaluated Inventiva’s YAP-TEAD inhibitors in the treatment of Malignant Pleural Mesothelioma (MPM) Study results show the potential of Inventiva’s compounds to significantly reduce tumor growth, attenuate [...]
Inventiva présentera de nouveaux résultats de son programme YAP-TEAD en oncologie lors de la conférence spéciale de l’AACR dédiée à la voie Hippo
23/04/2019
Une nouvelle étude a évalué les inhibiteurs YAP-TEAD d’Inventiva dans le traitement du mésothéliome pleural malin (MPM) Les résultats de l’étude montrent le potentiel des molécules d’Inventiva pour réduire [...]
Dynamic Digital Radiography Receives FDA Clearance
23/04/2019
WAYNE, N.J., April 23, 2019 (GLOBE NEWSWIRE) -- Konica Minolta Healthcare Americas, Inc., announces that the transformative technology introduced at RSNA 2018, Dynamic Digital Radiography (DDR), has received 510(k) [...]
Tauriga Sciences Inc. Obtains Legal Analysis/Confirmation Letter from Preeminent CBD Sector Law Firm
23/04/2019
New York, NY, April 23, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating Company that operates through the development, distribution, [...]
First Clinical Program Initiated Using Nanoparticles to Treat Retinitis Pigmentosa
23/04/2019
2CTech, Inc. Completes $8 Million Series B Funding to Further Develop Novel Therapeutic Quantum Dots Treatment for Photovoltaic Stimulation of the Neural Retina IRVINE, Calif., April 23, 2019 (GLOBE NEWSWIRE) -- 2Ctech [...]
Cytovance® Biologics Promotes Matt Hamilton to Vice President, Finance
23/04/2019
OKLAHOMA CITY, April 23, 2019 (GLOBE NEWSWIRE) -- Cytovance® Biologics, Inc., a leading full-service biopharmaceutical contract manufacturer of mammalian and microbial biologics, has promoted Matt Hamilton to Vice [...]

Pages